In response to metformin, the activated form of AMPK directly phosphorylates PD-L1 in a manner that promotes its abnormal glycosylation, resulting in ER accumulation and ERAD, which contributes to enhanced cytotoxic T-cell activity against metformin-treated cancer cells. The gene discussed is CD274; the disease is cancer.